Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Alemtuzumab versus interferon beta-1a in early relapsing-remitting multiple sclerosis: post-hoc and subset analyses of clinical efficacy outcomes.
Testicular hypofunction and multiple sclerosis risk: a record-linkage study.
Ethnicity and prevalence of multiple sclerosis in east London.
Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.
Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis.
Comprehensive Immunophenotyping of CSF cells in relapsing-remitting multiple sclerosis patients with daclizumb therapy
Copaxone
Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis.
Comparative pharmacokinetics and pharmacodynamics of two recombinant human interferon beta-1a (IFN beta-1 a) products administered intramuscularly in healthy male and female volunteers.
Impaired NK-mediated regulation of T-cell activity in multiple sclerosis is reconstituted by IL-2 receptor modulation.
Patient centered decision making: Use of conjoint analysis to determine risk-benefit trade-offs for preference sensitive treatment choices.
Biogen Idec reports death of patient on its MS pill
Combined structural and functional patterns discriminating upper limb motor disability in multiple sclerosis using multivariate approaches.
Synaptic pathology: a shared mechanism in neurological disease.
Chemokine-enhanced migration of human peripheral blood mononuclear cells is antagonized by interferon beta-1b through an effect on matrix metalloproteinase-9.
Multiple sclerosis: Mitoxantrone promotes differential effects on immunocompetent cells in vitro.
Multiple Sclerosis Patient-Specific Primary Neurons Differentiated from Urinary Renal Epithelial Cells via Induced Pluripotent Stem Cells.
Maternal and perinatal outcomes in pregnancies with multiple sclerosis: a case-control study.
Our Products (page shows "Copaxone" as a trade name for glatiramer acetate)
Use of interleukin-2 for management of natalizumab-associated progressive multifocal leukoencephalopathy: case report and review of literature.
Receptos to deliver scientific presentation at Digestive Disease Week 2012 about the therapeutic role of RPC1063 in inflammatory bowel disease
Fumarate treatment in progressive forms of multiple sclerosis: first results of a single-center observational study.
Optical coherence tomography and neurodegeneration: are eyes the windows to the brain?
Vision Disturbances in Multiple Sclerosis.
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation.

Pages